Clinical outcomes of Modified Collaborative Ocular Melanoma Study IRIS plaques for treatment of iris, iridociliary, and ciliary body melanoma.

Timothy T XuJose S PulidoChristopher L DeufelKimberly S CorbinIvy A PetersenLauren A Dalvin

Published in: Eye (London, England) (2020)

COMS IRIS plaques are effective for treatment of iris, iridociliary, and ciliary body melanoma with modest VA outcomes and low frequency of local tumour recurrence, enucleation, radiation side effects, and systemic metastasis.

Keyphrases

skin cancer
type diabetes
combination therapy
adipose tissue
quality improvement
skeletal muscle
insulin resistance